Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Daiichi Sankyo Company, Ltd. v. Accord Healthcare Inc., USA, No. 17-1052 (Fed. Cir. Dec. 12, 2017)

Affirmed
Rule 36 Affirmance
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 17-1052
Decided
December 12, 2017
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
3 pages
Download Opinion (PDF)

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit

DAIICHI SANKYO COMPANY, LTD., UBE

INDUSTRIES LTD.,

Appellants

v.

ACCORD HEALTHCARE INC., USA, ACCORD

HEALTHCARE, INC., INTAS PHARMACEUTICALS

LTD., AMNEAL PHARMACEUTICALS LLC,

AMNEAL PHARMACEUTICALS OF NEW YORK,

LLC, AMNEAL PHARMACEUTICALS CO. INDIA PVT. LTD., APOTEX CORP., APOTEX INC., DR.

REDDY'S LABORATORIES, LTD., DR. REDDY'S

LABORATORIES, INC., PANACEA BIOTEC LTD.,

SUN PHARMA GLOBAL FZE, TEVA

PHARMACEUTICALS USA, INC., ZYDUS

PHARMACEUTICALS USA, INC., CADILA

HEALTHCARE LTD., LUPIN LTD., LUPIN

PHARMACEUTICALS, INC.,

Appellees

2017-1052, 2017-1053

Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2015-00864, IPR2015-00865, IPR2015-01881, IPR2015-01882.

2JUDGMENT

ADAM LAWRENCE PERLMAN, Williams & Connolly LLP, Washington, DC, argued for appellants. Also represented by DOV PHILIP GROSSMAN, DAVID M. KRINSKY, ALLISON JONES RUSHING, CHRISTOPHER ALAN SUAREZ.

GEORGE C. LOMBARDI, Winston & Strawn LLP, Chicago, IL, argued for all appellees. Appellees Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals Co. India Pvt. Ltd., Apotex Corp., Apotex Inc., Panacea Biotec Ltd., Sun Pharma Global FZE, Teva Pharmaceuticals USA, Inc. also represented by SAMUEL S. PARK, MAUREEN L. RURKA; CHARLES B. KLEIN, EIMERIC REIG-PLESSIS, Washington, DC.

MICHAEL R. DZWONCZYK, Sughrue Mion PLLC, Washington, DC, for appellees Accord Healthcare Inc., USA, Accord Healthcare, Inc., Intas Pharmaceuticals Ltd. Also represented by AZADEH S. KOKABI. WILLIAM L. MENTLIK, Lerner, David, Littenberg, Krumholz & Mentlik LLP, Westfield, NJ, for appellees Dr. Reddy’s Laboratories, Ltd., Dr. Reddy’s Laboratories, Inc. Also represented by PAUL HILGER KOCHANSKI. STEVEN J. MOORE, Withers Bergman LLP, Greenwich, CT, for appellees Zydus Pharmaceuticals USA, Inc., Cadila Healthcare Ltd. DOUGLASS C. HOCHSTETLER, Kelley Drye & Warren, LLP, Chicago, IL, for appellees Lupin Ltd., Lupin Pharmaceuticals, Inc. Also represented by CLIFFORD KATZ, New York, NY.

3THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (LOURIE, O’MALLEY, and WALLACH, Cir-

cuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

December 12, 2017 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Daiichi Sankyo Company, Ltd. v. Accord Healthcare Inc., USA, No. 17-1052 (Fed. Cir. Dec. 12, 2017).

Record ID
CAFC-17-1052-20171212
Permalink
https://patentcasewatch.com/opinions/CAFC-17-1052-20171212

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.

Source: Federal Circuit opinions and orders · retrieved August 15, 2026 · Report an error